David Demedts
Impact in
- Physiology top 10%
- Alzheimer's disease research and treatments
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Prion Diseases and Protein Misfolding 3
- Wnt/β-catenin signaling in development and cancer 3
- Melanoma and MAPK Pathways 1
-
- Alzheimer's disease research and treatments 6
- Calcium signaling and nucleotide metabolism 1
- Co-authors
- Fred Van Leuven (7 shared papers)Herman Devijver (5 shared papers)Peter Borghgraef (4 shared papers)Benoit Lechat (4 shared papers)Tomasz Jaworski (3 shared papers)Sebastian Kügler (2 shared papers)Hans Duimel (1 shared paper)Fons Verheyen (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (1 paper)Current Alzheimer Research (1 paper)Nature (1 paper)Journal of Neuroscience (1 paper)American Journal Of Pathology (1 paper)
- Partner nations
- BelgiumUnited StatesGermany
In The Last Decade
David Demedts
10 papers receiving 412 citations
Peers
Comparison fields: 5 of 57
- Physiology 274
- Neurology 77
- Biological Psychiatry 20
- Cellular and Molecular Neuroscience 107
- Pharmacology 61
Countries citing papers authored by David Demedts
This map shows the geographic impact of David Demedts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Demedts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Demedts more than expected).
Fields of papers citing papers by David Demedts
This network shows the impact of papers produced by David Demedts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Demedts. The network helps show where David Demedts may publish in the future.
Co-authors
The 25 scholars most cited alongside David Demedts, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 99 | |
| 2 | 2011 | 94 | |
| 3 | 2009 | 70 | |
| 4 | 2011 | 45 | |
| 5 | 2012 | 40 | |
| 6 | 2013 | 23 | |
| 7 | 2013 | 21 | |
| 8 | 2020 | 13 | |
| 9 | 2021 | 9 | |
| 10 | GSK-3 alpha/beta kinases and amyloid production in vivo | 2011 | 4 |
About David Demedts
David Demedts is a scholar working on Molecular Biology, Physiology, Cellular and Molecular Neuroscience, Neurology and Cell Biology, having authored 10 papers that have together received 418 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (6 papers), Prion Diseases and Protein Misfolding (3 papers), Wnt/β-catenin signaling in development and cancer (3 papers), Neuroscience and Neuropharmacology Research (2 papers), Cellular transport and secretion (2 papers), Dermatological and Skeletal Disorders (1 paper), Melanoma and MAPK Pathways (1 paper) and Calcium signaling and nucleotide metabolism (1 paper). The work is most often cited by research in Physiology (274 citations), Neurology (77 citations), Biological Psychiatry (20 citations), Cellular and Molecular Neuroscience (107 citations) and Pharmacology (61 citations). David Demedts has collaborated with scholars based in Belgium, United States and Germany. Frequent co-authors include Fred Van Leuven, Herman Devijver, Peter Borghgraef, Benoit Lechat, Tomasz Jaworski, Sebastian Kügler, Hans Duimel, Fons Verheyen, Lujia Zhou and Bart De Strooper. Their work appears in journals such as Journal of Medicinal Chemistry, Current Alzheimer Research, Nature, Journal of Neuroscience and American Journal Of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.